Dual-Prep registry: Atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registry, 1-year results
Authors:
Open Access
- 19 March 2026
- journal article
- research article
- Published by Springer Nature in Cardiovascular Intervention and Therapeutics
- Vol. 41 (3) , 530-539
Abstract
Combination therapy with atherectomy and intravascular lithotripsy (IVL) has emerged as a promising strategy for the treatment of severely calcified occlusive coronary lesions, which potentially enhances procedural efficacy without increasing complication risk. The Dual-Prep Registry is a multicenter, prospective registry designed to evaluate the safety and efficacy of IVL after atherectomy in severely calcified lesions. Combined use was selectively applied when the risk of complications was anticipated to be high with a larger atherectomy burr size, or when it was deemed non-beneficial due to unfavorable guidewire bias. All adverse events were adjudicated by a clinical events committee. Kaplan–Meier analysis was performed to evaluate the primary endpoint of major adverse cardiovascular events (MACE; composite endpoint of cardiac death, myocardial infarction, and target vessel revascularization [TVR]) at 1 year. A total of 118 cases (120 lesions) were enrolled across 20 facilities. Significant comorbidities included diabetes in 56.8% of patients and hemodialysis-dependence in 25.4%. Calcification score after atherectomy was 4.0 in all cases, and calcified nodules were present in 41.7% (core-lab analysis) of cases. One-year follow-up was complete in 99.2% patients. MACE occurred in 7.6% patients at one year (cardiac death 2.5%, myocardial infarction 5.1%, TVR 5.1%) and stent thrombosis was observed in 1 case. Atherectomy followed by IVL resulted in low 1-year rates of MACE, TVR, and stent thrombosis in patients with severely calcified coronary lesions. This approach may be considered for lesions where an “IVL-first” strategy is difficult to apply. Japan Registry of Clinical Trials: jRCT1032230384. URL: https://jrct.mhlw.go.jp. Graphical AbstractKeywords
Funding Information
- Shockwave Medical Inc.
This publication has 21 references indexed in Scilit:
- Clinical and Technical Predictors of Adverse Cardiovascular Events Following Coronary Lithotripsy in the BENELUX-IVL RegistryThe American Journal of Cardiology, 2025
- Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registryCardiovascular Intervention and Therapeutics, 2025
- Contemporary Trends and Outcomes of Intravascular Lithotripsy in Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2024
- Calcified Nodule in Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2024
- Device indication for calcified coronary lesions based on coronary imaging findingsCardiovascular Intervention and Therapeutics, 2023
- Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics: update 2023Cardiovascular Intervention and Therapeutics, 2023
- Revascularization for Coronary Artery Disease: Principle and Challenges2020
- Orbital Atherectomy for Treating De Novo Severely Calcified Coronary Narrowing (1-Year Results from the Pivotal ORBIT II Trial)The American Journal of Cardiology, 2015
- Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II)JACC: Cardiovascular Interventions, 2014
- High-Speed Rotational Atherectomy Before Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary LesionsJACC: Cardiovascular Interventions, 2013